Rafferty Asset Management’s Vaxcyte PCVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.36M | Buy |
164,823
+33,011
| +25% | +$1.07M | 0.02% | 385 |
|
|
2025
Q1 | $4.98M | Sell |
131,812
-15,624
| -11% | -$590K | 0.02% | 371 |
|
|
2024
Q4 | $12.1M | Buy |
147,436
+82,940
| +129% | +$6.79M | 0.04% | 259 |
|
|
2024
Q3 | $7.37M | Sell |
64,496
-30,187
| -32% | -$3.45M | 0.03% | 333 |
|
|
2024
Q2 | $7.15M | Sell |
94,683
-31,481
| -25% | -$2.38M | 0.03% | 337 |
|
|
2024
Q1 | $8.62M | Sell |
126,164
-32,249
| -20% | -$2.2M | 0.03% | 323 |
|
|
2023
Q4 | $9.95M | Sell |
158,413
-5,481
| -3% | -$344K | 0.04% | 281 |
|
|
2023
Q3 | $8.36M | Sell |
163,894
-415
| -0.3% | -$21.2K | 0.05% | 272 |
|
|
2023
Q2 | $8.21M | Sell |
164,309
-15,572
| -9% | -$778K | 0.05% | 263 |
|
|
2023
Q1 | $6.74M | Sell |
179,881
-10,421
| -5% | -$391K | 0.05% | 304 |
|
|
2022
Q4 | $9.12M | Buy |
190,302
+96,889
| +104% | +$4.65M | 0.08% | 203 |
|
|
2022
Q3 | $2.24M | Buy |
93,413
+42,030
| +82% | +$1.01M | 0.02% | 485 |
|
|
2022
Q2 | $1.12M | Sell |
51,383
-6,665
| -11% | -$145K | 0.01% | 611 |
|
|
2022
Q1 | $1.4M | Buy |
58,048
+11,792
| +25% | +$285K | 0.01% | 707 |
|
|
2021
Q4 | $1.1M | Buy |
46,256
+18,177
| +65% | +$432K | 0.01% | 825 |
|
|
2021
Q3 | $712K | Sell |
28,079
-24,827
| -47% | -$630K | ﹤0.01% | 962 |
|
|
2021
Q2 | $1.19M | Sell |
52,906
-37,877
| -42% | -$853K | 0.01% | 823 |
|
|
2021
Q1 | $1.79M | Buy |
90,783
+81,771
| +907% | +$1.62M | 0.01% | 652 |
|
|
2020
Q4 | $239K | Buy |
+9,012
| New | +$239K | ﹤0.01% | 930 |
|